$58.00
0.120.21%
Pre-Market: 7:35 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Bristol-Myers Squibb (BMY) was reported on October 31, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $0.75 to $0.95, compared to the estimated EPS of $0.71. Additionally, Bristol-Myers Squibb forecasted revenue between $47.26B and $47.26B for the quarter.
Browse guidance and forecast on all stocks.